Executive Leader / Business Intelligence (Analytics)

Selected for Cohort 4 of Antler Malaysia, a highly selective regional startup accelerator. Successfully launched a startup and won the accelerator program run by 1337 Ventures. Pitched to senior executives across 30 life sciences companies and venture capital firms deploying USD 150K+ pre-seed investments. Developed and validated a differentiated value proposition that clearly positioned the venture against incumbent competitors.

Delivered KPI analysis and trend insights during monthly metric reviews. Equipped senior leadership with actionable recommendations, improving visibility into key OKRs and growth opportunities. Identified performance trends, played a key role in the successful migration of Grab’s concierge platform. Diagnosed and resolved frontend clickstream tracking issues, restoring accurate analytics and correcting a 4% deviation in Home CTR metric, improving data reliability across teams. Built and maintained ETL pipelines and interactive dashboards that provided stakeholders with real-time operational insights, enabling faster decision-making. Conducted deep feature analysis using frontend and backend data to support feature prioritization, helping the product team focus on high-impact initiatives aligned with business objectives.

Leveraged analytics, market intelligence, and cross-functional collaboration to generate actionable insights that helped increase the local franchise market rank from #5 (2019) to #2 (2023). Built automated Power BI dashboards to track recurring commercial KPIs, enabling real-time reporting to senior leadership and faster data-driven decision making. Led analytics-driven exploration of new business opportunities, identifying key market trends and growth areas that contributed to the organization growing 3× faster than the market in 2023. Forecasted revenue to support workforce planning, sales incentive design, and financial budgeting. Designed and deployed AI/ML models to enhance customer segmentation and targeting, improving salesforce engagement strategies. Established data governance strategies to ensure data integrity, enable smooth database migration, and improve overall data quality. Integrated Malaysian healthcare professional datasets from multiple public repositories into the company CRM, generating 9,000+ new leads for the salesforce. Recipient of the Country President Award (2021 & 2022) for outstanding contributions to organizational growth, including supporting AstraZeneca Malaysia’s growth during COVID-19 and leading Project 3i, a multi-source analytics dashboard initiative delivering integrated insights and long-term commercial impact.

Led the organisation-wide adoption of Power BI, eliminating manual Excel-based reporting and significantly improving employee productivity through automated data pipelines and real-time dashboards. Directed months-long BI transformation project, coordinating cross-functional teams to gather business requirements, integrate disparate data sources, and implement scalable analytics that strengthened the company’s data-driven culture. Developed and presented sales forecasting models using R to the leadership team, translating machine-learning insights into actionable strategic decisions. Built Customer Lifetime Value (CLV) models by segment, enabling more accurate budgeting and optimizing marketing spend allocation. Initiated and managed an AI partnership between Lauretta and StoreHub to detect fraudulent transactions, improving risk management and transaction monitoring capabilities. Strategized StoreHub’s entry into the digital retail ecosystem, expanding the company’s product verticals and positioning the platform as a more comprehensive solution for merchants.

Founded and scaled a niche skincare brand, introducing a new product to the Malaysian market. Secured distribution across leading natural-based pharmacies in the Klang Valley (4 physical retail outlets) and 5 partner e-commerce platforms. Built and managed the company’s direct-to-consumer online store, establishing a strong digital presence.

Advised Top-20 Asia-Pacific pharmaceutical companies on growth strategy and market expansion initiatives. Conducted systematic analysis of 3,000+ therapeutic entities in China, evaluating profitability and market feasibility to identify high-potential product innovation opportunities. Enabled client market entry prioritization by identifying commercially viable pipeline candidates, sharpening product innovation focus. Achieved perfect client engagement scores for delivery quality and strategic impact. Identified ~US$360M market opportunity for a client’s immunology portfolio through market sizing and portfolio analysis.